Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. - Wikidata - wikimedia - TriplyDB

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

http://www.wikidata.org/entity/Q33369676

about

Induction of monocyte-to-dendritic cell maturation by extracorporeal photochemotherapy: initiation via direct platelet signaling.Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.Current and future approaches for control of graft-versus-host disease.Chronic graft-versus-host disease (GVHD) in children.Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis.Current issues in chronic graft-versus-host disease.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD.Mesenchymal stem cell as salvage treatment for refractory chronic GVHD Four cases of corneal perforation in patients with chronic graft-versus-host disease Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases.Guidelines on the use of extracorporeal photopheresis Extracorporeal photopheresis in addition to pentostatin in conditioning for canine hematopoietic cell transplantation: role in engraftment.The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma Biomarkers in chronic graft-versus-host disease Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.Treatment of chronic graft-versus-host disease: Past, present and future.How I treat refractory acute GVHD.Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.Extracorporeal photophoresis: an evidence-based analysis Clinical Results of Extracorporeal Photopheresis Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.Interleukin-10 spot-forming cells as a novel biomarker of chronic graft-versus-host disease.Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantation Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.Extracorporeal photopheresis in graft-versus-host disease.U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion Therapy of chronic graft-versus-host disease.Immune modulation and chronic graft-versus-host disease.International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I).GVHD: a continuing barrier to the safety of allogeneic transplantation Treatment and management of graft-versus-host disease: improving response and survival.Immunosuppressive effects of multipotent mesenchymal stromal cells on graft-versus-host disease in rats following allogeneic bone marrow transplantation.Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease.UV-induced immunosuppressive and anti-inflammatory actions: mechanisms and clinical applications.Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.

P2860

Q30587203-5870C333-5604-4C76-96A3-895F2F9D8807 Q33165774-420B40CB-6BF9-4795-AD60-10D6145FC267 Q33625948-4217B1B1-6005-4C1A-9114-1C4D2298D86C Q33642625-23B09760-AF3F-40D1-87CE-DEC33E81FC67 Q33857680-C3446169-FCDB-48DD-927B-A482CFC12F1C Q33875879-6296EAC1-6F45-46C9-BE80-CCAB993FD549 Q33917187-3E22662A-348E-49DC-BDD2-C0368407F39D Q34122035-46084B97-AE8C-4369-9F19-F32960700B52 Q34135339-83D0F09C-F227-4E38-BE17-3EB9ED73026D Q34562177-BAE68F5E-14F0-4E0F-8D5C-E5C08DB77A7F Q34628627-CB4A8E4D-2188-4678-A9FF-4724A1294D9B Q34870346-4C87EEF4-2810-41A5-9714-98EF806C326B Q34918643-F36BF28A-EB4D-49BE-B833-0D8C8C791626 Q35050513-37CE122A-ADA5-4A15-91FC-9086182C52ED Q35084404-7DD45FE2-5105-4479-8575-A153E08A4F08 Q35094374-6B598CE8-7121-4BE0-8C84-1F75E91CAA10 Q35174524-632794A4-7020-4ED1-8A2F-5EEFDAE18F6A Q35495340-52ED14FF-35D4-4358-A726-C5188ADB6903 Q35524687-DBEDA83A-679F-4E3D-B4CF-EDE427DCE7E2 Q35828633-5701988E-ED98-4C84-96D9-5732B80B258E Q36036186-EBA8D4C8-08FF-4930-A8A1-DC87965662DD Q36046989-42A7F73B-B447-4F1A-AFB1-EDBA4F196809 Q36210320-B844CB0B-89E4-4019-A31F-D15C8FC306D0 Q36252702-655A216B-D322-43B4-91D1-1B0EAB68E5B6 Q36443116-345A4FFF-84D1-48EF-8817-3B015F4CDF56 Q36498345-5E3E0E8A-D774-47BC-B21B-6048B2926623 Q36891433-9CEA3C64-6A4C-417B-ACC0-6F3B463E8062 Q36925994-037C4BD3-AAC7-487D-A50D-8A13C1324116 Q37051405-77023949-7AF3-4AB9-AF4A-253BBAFBC70F Q37074253-BCE61F16-62A6-43BF-BEB6-DDE31B5E113B Q37154179-C755D3B1-FD4D-4703-8B58-DC5C485DE719 Q37173479-F14B9039-62ED-4E20-B171-9EF21725DDD8 Q37251057-C8CFC89E-AD11-4DEF-B7BD-EDB5EF03F18C Q37365681-D51DB127-A47B-480D-A59A-49BC86C793B6 Q37369447-0AC8C450-2AC2-422D-8705-70FE1831ECA9 Q37371836-F110C8D5-C335-4FC8-9BB3-76E5D35EBC41 Q37426583-E850E334-B80E-4FBD-A81B-CD5148BFAE50 Q37453628-B3332BA8-5A32-4EB3-A7DE-B39F8B8B9E5D Q37773262-21C02B7C-080B-4B9E-ADFD-0517EFB3060F Q37858415-113C4F1A-A5EE-4B39-9EC2-4663CF830FA8

P2860

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

http://www.wikidata.org/entity/Q33369676

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

@ast

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

@en

type

label

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

@ast

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

@en

prefLabel

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

@ast

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

@en

P1433

Q33369676-5190F21B-4026-4A9C-A645-1C065657C500

P1476

Q33369676-AE9B4EA6-44D4-497F-95FC-E56FA4372C9F

P2093

Q33369676-0E020A14-56A6-460F-8B15-7E5C0E38FAAF

Q33369676-0EF326FE-06E1-4AF1-A292-A1D42841BAEB

Q33369676-171AB746-23D5-48CF-86D0-C76506A94388

Q33369676-441FBCCF-D3DF-44AD-8330-F74B91A61B70

Q33369676-5167DA5C-F4FE-4F32-89A4-D5A66D018E37

Q33369676-57A7ACF7-4CFC-470C-8034-6CED536CFB78

Q33369676-717AEBCF-41A1-498E-862A-3209596F95FF

Q33369676-8B387CF2-CE6C-47EC-9223-802A93A390D8

Q33369676-9DC4C956-5B4C-4815-9435-429EDB812835

Q33369676-A17F1959-C2DC-4885-A0B2-D793C57AE932

P304

Q33369676-50EFD434-A2E5-429D-8D94-873F8FB0F401

P31

Q33369676-402C5B17-6F88-4A24-8A65-87FB9C4B15BA

P356

Q33369676-24607D1B-4D63-4110-9DCD-D41447058953

P407

Q33369676-E6439CE1-E70D-4CAF-B045-24F0018CF809

P433

Q33369676-E073C7A5-17BC-45BD-B4FF-9C7DDBC1063F

P478

Q33369676-286337E6-A499-4F4A-8046-C68B6ADEC45D

P50

Q33369676-07CC96B9-9251-4351-92E4-12891A1CD290

Q33369676-FE5FB2F1-4F16-4472-A9FA-4AD4052B239D

P577

Q33369676-5FC28326-23CF-457B-BE4E-C1BD8D0F0FB0

P5875

Q33369676-529A1FE6-D6D2-4092-A868-6BA334B25B5D

P698

Q33369676-43CD4C17-002F-4CB8-92F5-F7D63B3DD017

P356

BLOOD-2005-09-3907

P1433

P1476

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

@en

P2093

Beverly Rhodes

http://www.w3.org/2001/XMLSchema#string

Borje Andersson

http://www.w3.org/2001/XMLSchema#string

Daniel R Couriel

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Shpall

http://www.w3.org/2001/XMLSchema#string

Issa Khouri

http://www.w3.org/2001/XMLSchema#string

Joyce Neumann

http://www.w3.org/2001/XMLSchema#string

Marcos de Lima

http://www.w3.org/2001/XMLSchema#string

Michele Donato

http://www.w3.org/2001/XMLSchema#string

Muzzafar Qazilbash

http://www.w3.org/2001/XMLSchema#string

Paolo Anderlini

http://www.w3.org/2001/XMLSchema#string

P304

3074-3080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2005-09-3907

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7401828

http://www.w3.org/2001/XMLSchema#string

P698

16368882

http://www.w3.org/2001/XMLSchema#string